Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China flag China · Delayed Price · Currency is CNY
19.09
+0.65 (3.52%)
At close: Mar 27, 2026

SHE:300497 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-272.1-200.8-141.4748.83
Depreciation & Amortization
170.72159.46123.8498.57
Other Amortization
0.37--1.13
Loss (Gain) From Sale of Assets
0.1-0.08-0.410.06
Asset Writedown & Restructuring Costs
101.6324.8813.895.93
Loss (Gain) From Sale of Investments
15.5216.191.4447.94
Provision & Write-off of Bad Debts
-0.870.910.79-
Other Operating Activities
85.649178.996.84
Change in Accounts Receivable
13.09-159.45-273.95-199.39
Change in Inventory
-44.874.55-259.58-154.85
Change in Accounts Payable
128.91-33.38232.27139.1
Change in Other Net Operating Assets
-7.031.666.32
Operating Cash Flow
187.64-64.76-120.8572.32
Operating Cash Flow Growth
----81.08%
Capital Expenditures
-141.75-242.23-459.41-679.6
Sale of Property, Plant & Equipment
1.11.613.810.3
Investment in Securities
--114.72-53.6-73.25
Other Investing Activities
1.040.830.8717.06
Investing Cash Flow
-139.61-354.5-508.34-735.48
Long-Term Debt Issued
641956.441,2411,048
Long-Term Debt Repaid
-658.78-729.98-830.49-488.5
Net Debt Issued (Repaid)
-17.78226.47410.51559.11
Issuance of Common Stock
---34.79
Repurchase of Common Stock
-18--69.75-105.11
Common Dividends Paid
-55.5-55.79-54.58-139.18
Other Financing Activities
3.5-20.91-3.2-
Financing Cash Flow
-87.78149.76282.99349.61
Foreign Exchange Rate Adjustments
7.8339.510.74
Net Cash Flow
-31.92-266.5-336.69-312.81
Free Cash Flow
45.89-306.99-580.26-607.28
Free Cash Flow Margin
3.90%-19.07%-35.23%-42.48%
Free Cash Flow Per Share
0.09-0.57-1.07-1.12
Cash Income Tax Paid
-98.69-15.84-54.0119.34
Levered Free Cash Flow
66.66-379.88-536.77-490.78
Unlevered Free Cash Flow
92.02-353.61-511.08-475.2
Change in Working Capital
89.04-115.96-300.32-226.98
Source: S&P Global Market Intelligence. Standard template. Financial Sources.